Ndvr, Inc. United Therapeutics Corp Transaction History
Ndvr, Inc.
- $104 Billion
- Q4 2024
A detailed history of Ndvr, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Ndvr, Inc. holds 644 shares of UTHR stock, worth $206,112. This represents 0.22% of its overall portfolio holdings.
Number of Shares
644
Previous 578
11.42%
Holding current value
$206,112
Previous $207 Million
9.65%
% of portfolio
0.22%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
61MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$5.86 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.75 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.42 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$883 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$789 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.6B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...